51339-31-2Relevant academic research and scientific papers
Preparation and application of organic thermally induced delayed fluorescence material containing 9,9-dimethyl acridine unit
-
, (2017/08/31)
The invention belongs to the field of organic luminescent materials, and provides preparation and application of an organic thermally induced delayed fluorescence material containing a 9,9-dimethyl acridine unit. Isophthalonitrile with high eletrophilicity is taken as the electron acceptor, a cyano group with a strong electron-withdrawing performance is introduced, 9,9-dimethyl acridine is taken as the electron donor, and a meta-position connection mode is adopted to obtain the organic micromolecular thermally induced delayed fluorescence material with an excellent luminescence property, and the conventional para-position connection mode is broken through. The organic thermally induced delayed fluorescence material, which contains a 9,9-dimethyl acridine unit and adopts a meta-position connection mode, can be applied to vapor deposition of devices. Meanwhile, the organic thermally induced delayed fluorescence material has the advantages of high yield, high thermal stability, and easy film forming, can be massively produced and used in a large scale, and can be applied to electroluminescent devices to obtain a high efficient electroluminescent performance.
Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors
-
Page/Page column 51, (2010/02/10)
Certain aza- and polyaza-naphthalenyl ketones including certain quinolinyl and naphthyridinyl ketones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment or the delay in the onset of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells
Zhuang, Linghang,Wai, John S.,Embrey, Mark W.,Fisher, Thorsten E.,Egbertson, Melissa S.,Payne, Linda S.,Guare Jr., James P.,Vacca, Joseph P.,Hazuda, Daria J.,Felock, Peter J.,Wolfe, Abigail L.,Stillmock, Kara A.,Witmer, Marc V.,Moyer, Gregory,Schleif, William A.,Gabryelski, Lori J.,Leonard, Yvonne M.,Lynch Jr., Joseph J.,Michelson, Stuart R.,Young, Steven D.
, p. 453 - 456 (2007/10/03)
Naphthyridine 7 inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 μM. It does not exhibit cytotoxicity in cell culture
1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
-
Page 30, (2010/02/06)
Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
HIV integrase inhibitors
-
, (2008/06/13)
Certain six-membered aromatic and heteroaromatic-dioxobutyric acid derivatives are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment
Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4- chlorophenyl)sulfonyl}-amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists
Dack, Kevin N.,Dickinson, Roger P.,Long, Clive J.,Steele, John
, p. 2061 - 2066 (2007/10/03)
The design of a series of thromboxane receptor antagonists based on 3- (2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid (1) is described. Addition of an arylmethyl group at the 5-position of 1 gave exceptionally potent agents in vitro and in vivo, with 13a (UK-147,535) giving complete blockade of the TxA2 receptor for greater than 12 hours in dogs, following an oral dose of 0.1 mg/kg.
